UniProt ID | CELF2_HUMAN | |
---|---|---|
UniProt AC | O95319 | |
Protein Name | CUGBP Elav-like family member 2 | |
Gene Name | CELF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 508 | |
Subcellular Localization | Nucleus. Cytoplasm. Accumulates in the cytoplasm after ionizing radiation (By similarity). Colocalizes with APOBEC1 and A1CF. RNA-binding activity is detected in both nuclear and cytoplasmic compartments.. | |
Protein Description | RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of TNNT2 in embryonic, but not adult, skeletal muscle. Activates TNNT2 exon 5 inclusion by antagonizing the repressive effect of PTB. Acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre-mRNAs. Promotes inclusion of exonS 21 and exclusion of exon 5 of the NMDA receptor R1 pre-mRNA. Involved in the apoB RNA editing activity. Increases COX2 mRNA stability and inhibits COX2 mRNA translation in epithelial cells after radiation injury (By similarity). Modulates the cellular apoptosis program by regulating COX2-mediated prostaglandin E2 (PGE2) expression (By similarity). Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK. Binds to the muscle-specific splicing enhancer (MSE) intronic sites flanking the TNNT2 alternative exon 5. Binds preferentially to UG-rich sequences, in particular UG repeat and UGUU motifs. Binds to apoB mRNA, specifically to AU-rich sequences located immediatly upstream of the edited cytidine. Binds AU-rich sequences in the 3'-UTR of COX2 mRNA (By similarity). Binds to an intronic RNA element responsible for the silencing of exon 21 splicing (By similarity). Binds to (CUG)n repeats (By similarity). May be a specific regulator of miRNA biogenesis. Binds to primary microRNA pri-MIR140 and, with CELF1, negatively regulates the processing to mature miRNA. [PubMed: 28431233] | |
Protein Sequence | MRCPKSAVTMRNEELLLSNGTANKMNGALDHSDQPDPDAIKMFVGQIPRSWSEKELKELFEPYGAVYQINVLRDRSQNPPQSKGCCFVTFYTRKAALEAQNALHNIKTLPGMHHPIQMKPADSEKSNAVEDRKLFIGMVSKKCNENDIRVMFSPFGQIEECRILRGPDGLSRGCAFVTFSTRAMAQNAIKAMHQSQTMEGCSSPIVVKFADTQKDKEQRRLQQQLAQQMQQLNTATWGNLTGLGGLTPQYLALLQQATSSSNLGAFSGIQQMAGMNALQLQNLATLAAAAAAAQTSATSTNANPLSTTSSALGALTSPVAASTPNSTAGAAMNSLTSLGTLQGLAGATVGLNNINALAGMAALNGGLGATGLTNGTAGTMDALTQAYSGIQQYAAAALPTLYSQSLLQQQSAAGSQKEGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQAMNGFQIGMKRLKVQLKRSKNDSKPY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
32 | Phosphorylation | MNGALDHSDQPDPDA CCCCCCCCCCCCHHH | 37.29 | 28450419 | |
52 | Phosphorylation | GQIPRSWSEKELKEL CCCCCCCCHHHHHHH | 39.78 | 23401153 | |
54 | Ubiquitination | IPRSWSEKELKELFE CCCCCCHHHHHHHHH | 63.93 | - | |
57 | Ubiquitination | SWSEKELKELFEPYG CCCHHHHHHHHHCCC | 54.16 | - | |
58 (in isoform 4) | Phosphorylation | - | 71.91 | 25147952 | |
59 (in isoform 2) | Ubiquitination | - | 5.87 | 21890473 | |
59 (in isoform 5) | Ubiquitination | - | 5.87 | 21890473 | |
63 | Phosphorylation | LKELFEPYGAVYQIN HHHHHHCCCEEEEEE | 15.54 | - | |
67 | Phosphorylation | FEPYGAVYQINVLRD HHCCCEEEEEEEECC | 11.80 | - | |
76 | Phosphorylation | INVLRDRSQNPPQSK EEEECCCCCCCCCCC | 38.30 | - | |
78 (in isoform 3) | Ubiquitination | - | 52.01 | 21890473 | |
83 (in isoform 1) | Ubiquitination | - | 51.20 | 21890473 | |
83 | Acetylation | SQNPPQSKGCCFVTF CCCCCCCCCEEEEEE | 51.20 | 26051181 | |
83 | Ubiquitination | SQNPPQSKGCCFVTF CCCCCCCCCEEEEEE | 51.20 | 21906983 | |
90 (in isoform 4) | Ubiquitination | - | 5.01 | 21890473 | |
94 | Ubiquitination | FVTFYTRKAALEAQN EEEEECHHHHHHHHH | 30.16 | - | |
107 | Ubiquitination | QNALHNIKTLPGMHH HHHHHCCCCCCCCCC | 49.69 | - | |
141 | Methylation | LFIGMVSKKCNENDI HHHHHHCCCCCCCCC | 50.35 | 23644510 | |
141 | Acetylation | LFIGMVSKKCNENDI HHHHHHCCCCCCCCC | 50.35 | 25953088 | |
151 | Sulfoxidation | NENDIRVMFSPFGQI CCCCCEEEEECCCCE | 1.66 | 21406390 | |
165 | Methylation | IEECRILRGPDGLSR EEEEEECCCCCCCCC | 52.83 | - | |
182 | Methylation | AFVTFSTRAMAQNAI EEEEEHHHHHHHHHH | 22.59 | - | |
185 (in isoform 4) | Ubiquitination | - | 9.86 | - | |
190 | Ubiquitination | AMAQNAIKAMHQSQT HHHHHHHHHHHHHHC | 36.93 | - | |
195 | Phosphorylation | AIKAMHQSQTMEGCS HHHHHHHHHCCCCCC | 16.97 | 23312004 | |
197 | Phosphorylation | KAMHQSQTMEGCSSP HHHHHHHCCCCCCCC | 23.57 | 23312004 | |
202 | Phosphorylation | SQTMEGCSSPIVVKF HHCCCCCCCCEEEEE | 50.43 | 23312004 | |
203 | Phosphorylation | QTMEGCSSPIVVKFA HCCCCCCCCEEEEEC | 23.79 | 23312004 | |
214 | Ubiquitination | VKFADTQKDKEQRRL EEECCCHHHHHHHHH | 73.24 | - | |
295 | O-linked_Glycosylation | AAAAAAQTSATSTNA HHHHHHHHCCCCCCC | 18.66 | 29485866 | |
296 | O-linked_Glycosylation | AAAAAQTSATSTNAN HHHHHHHCCCCCCCC | 19.92 | 29485866 | |
298 | O-linked_Glycosylation | AAAQTSATSTNANPL HHHHHCCCCCCCCCC | 35.53 | 29485866 | |
316 | Phosphorylation | SSALGALTSPVAAST HHHHHHHCCCCCCCC | 30.37 | 26074081 | |
317 | Phosphorylation | SALGALTSPVAASTP HHHHHHCCCCCCCCC | 20.44 | 26074081 | |
438 (in isoform 5) | Ubiquitination | - | 48.59 | 21890473 | |
440 (in isoform 2) | Ubiquitination | - | 3.98 | 21890473 | |
458 | Sumoylation | SAKVFIDKQTNLSKC EEEEEEECCCCHHHH | 54.96 | - | |
458 | Acetylation | SAKVFIDKQTNLSKC EEEEEEECCCCHHHH | 54.96 | 23954790 | |
458 (in isoform 1) | Ubiquitination | - | 54.96 | 21890473 | |
458 | Ubiquitination | SAKVFIDKQTNLSKC EEEEEEECCCCHHHH | 54.96 | - | |
458 | Malonylation | SAKVFIDKQTNLSKC EEEEEEECCCCHHHH | 54.96 | 26320211 | |
458 | 2-Hydroxyisobutyrylation | SAKVFIDKQTNLSKC EEEEEEECCCCHHHH | 54.96 | - | |
458 | Sumoylation | SAKVFIDKQTNLSKC EEEEEEECCCCHHHH | 54.96 | - | |
459 (in isoform 4) | Ubiquitination | - | 31.69 | 21890473 | |
471 (in isoform 3) | Ubiquitination | - | 17.90 | 21890473 | |
471 (in isoform 4) | Ubiquitination | - | 17.90 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CELF2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CELF2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CELF2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A1CF_HUMAN | A1CF | physical | 11577082 | |
APOB_RAT | Apob | physical | 11577082 | |
A4_HUMAN | APP | physical | 21832049 | |
PGH2_HUMAN | PTGS2 | physical | 17383427 | |
ELAV1_HUMAN | ELAVL1 | physical | 17383427 | |
TRAF3_HUMAN | TRAF3 | physical | 28031331 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-458, AND MASS SPECTROMETRY. |